Mode
Text Size
Log in / Sign up

Systematic review on neutrophil extracellular traps in gastrointestinal cancer progressionNeutrophil Extracellular Traps Linked to Gastrointestinal Cancer Progression

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that NETs may promote gastrointestinal cancer metastasis, but this narrative review does not establish clinical efficacy.

This is a systematic review that synthesizes narrative evidence on the role of neutrophil extracellular traps (NETs) in gastrointestinal cancer. The review's scope is to summarize mechanisms and therapeutic strategies related to NETs in tumor progression.

The authors synthesize that NETs exert a dual role in tumor progression. They directly promote metastasis by enhancing tumor cell migration, trapping circulating tumor cells, reactivating dormant cancer cells, and increasing vascular permeability. NETs also reshape the tumor microenvironment to support pre-metastatic niche formation.

The review is narrative and mechanistic; it does not report a quantitative synthesis, pooled effect sizes, or a formal certainty assessment. The authors note that this evidence does not establish causation from primary trials.

A key limitation is the lack of quantitative data, such as effect sizes or confidence intervals, which is not reported. Practice relevance is not reported, and clinicians should not infer specific therapeutic efficacy or clinical outcomes from this narrative review.

A systematic review examined how neutrophil extracellular traps (NETs) might influence the progression of gastrointestinal cancers. The authors summarized existing research on how NETs interact with tumor cells and the surrounding tissue environment.

The review suggests NETs may have a dual role. They could directly promote metastasis by helping tumor cells move, trapping circulating cancer cells, reawakening dormant cells, and making blood vessels leakier. NETs may also reshape the tumor microenvironment to help create a 'pre-metastatic niche,' a setting that supports future spread.

This work is a narrative synthesis of mechanisms, not a quantitative analysis of patient outcomes. It does not report safety data or clinical trial results. The main reason to be careful is that these findings are early and mechanistic; they do not prove that targeting NETs will be safe or effective in people.

Readers should view this as a helpful overview of a research area, not a guide for treatment. It highlights a potential biological process that may influence cancer, but more rigorous clinical studies are needed to understand any real-world impact.

What this means for you:
NETs may help gastrointestinal cancer spread, but this review does not show that targeting them improves patient outcomes.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
As the most abundant subset of leukocytes in the innate immune system, neutrophils are central to host defense, particularly against bacterial and fungal infections. With advances in tumor microenvironment (TME) research, their multifunctional roles in tumor biology have been clarified, and the identification of neutrophil extracellular traps (NETs) has provided a novel perspective for understanding neutrophil-mediated regulation of tumor initiation, progression, and metastasis. NETs are reticular structures of chromatin fibers released by activated neutrophils, comprising DNA backbones, histones, and various antimicrobial proteins, initially recognized as an antibacterial defense mechanism. However, recent studies reveal NETs exert a dual role in tumor progression: directly promoting metastasis by enhancing tumor cell migration, trapping circulating tumor cells (CTCs), reactivating dormant cancer cells, and increasing vascular permeability, while also reshaping the TME to support pre-metastatic niche formation. This review systematically summarizes the molecular mechanisms of NETs in gastrointestinal tumor initiation, progression, and metastasis, and explores potential NETs-targeted anti-tumor therapeutic strategies, aiming to provide a theoretical basis for novel gastrointestinal tumor treatment directions.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.